|
A Mild and Selective Method for the Hydrolysis of Esters with Trimethyltin Hydroxide
|
journal
|
February 2005 |
|
Preparation of 2-, 4-, 5-, and 6-aminonicotinic acid tert-butyl esters
|
journal
|
February 2012 |
|
A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors: LSD1 AND ITS INHIBITORS
|
journal
|
May 2015 |
|
Afatinib in advanced NSCLC: a profile of its use
|
journal
|
February 2018 |
|
[10] Mechanism-based enzyme inactivators
|
book
|
January 1995 |
|
Modeling covalent-modifier drugs
|
journal
|
November 2017 |
|
Synergistic cytotoxicity of afatinib and cetuximab against EGFR T790M involves Rab11-dependent EGFR recycling
|
journal
|
December 2014 |
|
Highly predictive and interpretable models for PAMPA permeability
|
journal
|
February 2017 |
|
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors
|
journal
|
July 2017 |
|
Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer
|
journal
|
October 2016 |
|
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
|
journal
|
June 2013 |
|
Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
|
journal
|
December 2004 |
|
RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethylated Lysine 4 on Histone 3
|
journal
|
March 2007 |
|
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
|
journal
|
April 2010 |
|
Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis
|
journal
|
March 2014 |
|
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
|
journal
|
May 2017 |
|
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds
|
journal
|
July 2016 |
|
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells
|
journal
|
March 2017 |
|
Targeting histone demethylases KDM5A and KDM5B in AML cancer cells: A comparative view
|
journal
|
May 2018 |
|
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
|
journal
|
November 2012 |
|
Engineered Covalent Inactivation of TFIIH-Kinase Reveals an Elongation Checkpoint and Results in Widespread mRNA Stabilization
|
journal
|
August 2016 |
|
Amazing Diversity in Biochemical Roles of Fe(II)/2-Oxoglutarate Oxygenases
|
journal
|
July 2018 |
|
JARID1 Histone Demethylases: Emerging Targets in Cancer
|
journal
|
October 2017 |
|
Inhibitors of Protein Methyltransferases and Demethylases
|
journal
|
March 2017 |
|
Systematic Study of the Glutathione (GSH) Reactivity of N -Arylacrylamides: 1. Effects of Aryl Substitution
|
journal
|
November 2015 |
|
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives
|
journal
|
April 2015 |
|
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4- d ]pyrimidin-4(3 H )-one Derivatives
|
journal
|
April 2015 |
|
Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase
|
journal
|
October 2016 |
|
Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5A
|
journal
|
March 2018 |
|
Noncryogenic I/Br−Mg Exchange of Aromatic Halides Bearing Sensitive Functional Groups Using i- PrMgCl−Bis[2-( N , N -dimethylamino)ethyl] Ether Complexes
|
journal
|
January 2006 |
|
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
|
journal
|
July 2012 |
|
Inhibition of demethylases by GSK-J1/J4
|
journal
|
October 2014 |
|
Prolonged and tunable residence time using reversible covalent kinase inhibitors
|
journal
|
May 2015 |
|
Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling
|
journal
|
March 2016 |
|
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
|
journal
|
May 2016 |
|
Structural analysis of human KDM5B guides histone demethylase inhibitor development
|
journal
|
May 2016 |
|
Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1
|
journal
|
July 2011 |
|
Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases
|
journal
|
December 2015 |
|
Carbon-Oxygen Hydrogen Bonding in Biological Structure and Function
|
journal
|
October 2012 |
|
Targeting of 5-aza-2′-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme
|
journal
|
March 2010 |
|
The Discovery of Histone Demethylases
|
journal
|
December 2013 |
|
Histone Lysine Demethylase Inhibitors
|
journal
|
October 2016 |
|
Association between H3K4 methylation and cancer prognosis: A meta-analysis: H3K4 methylation and cancer prognosis
|
journal
|
May 2018 |
|
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
|
journal
|
August 2012 |
|
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
|
journal
|
October 2012 |
|
Bioluminescent High-Throughput Succinate Detection Method for Monitoring the Activity of JMJC Histone Demethylases and Fe(II)/2-Oxoglutarate-Dependent Dioxygenases
|
journal
|
December 2017 |
|
KDM5 histone demethylases repress immune response via suppression of STING
|
journal
|
August 2018 |
|
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression
|
journal
|
June 2011 |
|
Reversible Michael Additions: Covalent Inhibitors and Prodrugs
|
journal
|
October 2012 |
|
The KDM5 family of histone demethylases as targets in oncology drug discovery
|
journal
|
June 2014 |
|
DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge
|
journal
|
January 2017 |
|
Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer
|
journal
|
March 2011 |